Egypt Edition 
MENA+ Edition 
UAE Edition 
Saudi Edition 
AI + Innovation (MENA) 
Logistics (MENA) 
Rameda acquires generic anti-inflammatory molecule
Rameda Pharma has acquired a generic anti-inflammatory molecule, according to a statement (pdf). The unnamed molecule, which relieves pain associated…
What we’re tracking on 02 April 2020
We do not recall the last time we were this grateful for Thursday to have rolled around. There’s lots of…
What we’re tracking on 26 March 2020
We are in the final minutes of the country’s first nighttime curfew in some seven years, and the streets were…
Egypt’s universal health coverage program suggests there’s plenty of untapped potential
Egypt’s universal health coverage suggests there’s plenty of untapped potential in the country’s healthcare and pharma sectors, Renaissance Capital said…
What we’re tracking on 2 March 2020
Egypt has its second known case of covid-19 this morning, the Health Ministry and World Health Organization said in a…
Pfizer is looking to increase investments in Egypt by USD 70 mn
INVESTMENT WATCH- Pharma giant Pfizer is looking to invest an additional USD 70 mn in Egypt “in the coming months,”…
Hardhat: East Port Said Industrial Zone
In this week’s edition of Hardhat, Enterprise had a chat with East Port Said Development’s (EPD) commercial director Shahira El…
Ibnsina registers profits of EGP 328.7 bn in 2019
EARNINGS WATCH- Ibnsina Pharma posted annual net profits of EGP 328.77 bn in 2019, a 25.24% y-o-y increase from the…
Something went wrong. Please refresh the page and/or try again.